Bank Of America Corp Belite Bio, Inc Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Belite Bio, Inc stock. As of the latest transaction made, Bank Of America Corp holds 18,342 shares of BLTE stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,342
Previous 13,451
36.36%
Holding current value
$1.12 Million
Previous $630,000
83.65%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BLTE
# of Institutions
22Shares Held
280KCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY168KShares$10.3 Million0.15% of portfolio
-
State Street Corp Boston, MA20KShares$1.22 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY14.6KShares$893,6740.0% of portfolio
-
Ubs Group Ag12.2KShares$745,3590.0% of portfolio
-
Morgan Stanley New York, NY10.6KShares$648,3350.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.52B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...